Progressive Pulmonary Fibrosis
Progressive Pulmonary Fibrosis is a rare lung disease characterized by the gradual scarring of lung tissue, which can lead to difficulty breathing and reduced oxygen supply to the body.
Progressive Pulmonary Fibrosis: Inhaled Treprostinil Study
We are investigating whether inhaled treprostinil can improve lung function in people with progressive pulmonary fibrosis. The study will also assess its safety and impact on overall health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have pulmonary fibrosis (lung scarring) diagnosed by a doctor?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications for lung disease like nintedanib or pirfenidone?
- Have you had a major lung problem like a pulmonary embolism in the last 90 days?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Onze-Lieve-Vrouwziekenhuis
Pneumology
Aalst, Belgium
Ziekenhuis Aan De Stroom
Pneumology
Berchem, Belgium
UZ Leuven
Pneumology
Heverlee, Belgium
Sponsor: United Therapeutics Corp.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.